The need for global, equitable access to medicines is urgent. Too many people in developing countries are dying because medicines are not available at prices they can afford and health agencies have limited budgets to pay high prices for brand-name drugs. People die because they cannot afford to buy life.
Our work focuses on laws and policies that affect access to antiretroviral and other medicines, such as patents rules in international trade agreements and domestic legislation regulating the price of medicines.
This includes ensuring access to
- comprehensive care, treatment and support for people living with HIV;
- diagnostic tools (such as HIV testing kits), antiretroviral treatment, and other medicines; and
- other kinds of health and support services, including treatment for people with immune systems weakened by HIV, sexual and reproductive health services, addiction treatment, and mental health services.
For the last five years, Canada and 11 other countries have been secretly negotiating the Trans-Pacific Partnership (TPP), often described as “NAFTA on steroids.” Among many other concerns, health groups have been sounding the alarm that access to affordable medicines for millions of people in the negotiating countries could be one of those things traded […]
“Ever since talks over the Trans-Pacific Partnership agreement (TPP) began over five years ago, there have been broad public calls on leaders to make negotiations more transparent and open to the public. In statements, in letters, and in face-to-face meetings with trade representatives, we have urged the adoption of concrete practices that would better enable the kind of open […]
“It is our understanding that Canada will host the next negotiating round of the Trans‐Pacific Partnership, including Chief Negotiators meetings, in Ottawa in early July…. [I]t is critical that Canada ensures and facilitates opportunities for civil society stakeholder engagement with negotiators during the Ottawa round of negotiations….”
“We, the undersigned organizations and activists from the global South and North, are writing to urge the Global Fund to abandon its attempt to launch a “blue-ribbon Task Force” that will focus primarily on developing a global multi-tiered pricing framework for middle-income countries (MICs), which we believe would permanently undermine access to more affordable medicines, […]
“On behalf of advocates for universal access to HIV prevention, treatment, care and support in Eastern Europe and Central Asia (EECA), we write to express our concerns about the Fourth Conference on HIV/AIDS in Eastern Europe and Central Asia (EECAAC) which is being organized with great influence from its host, the government of the Russian […]
“[W]e would like … to ask UNAIDS to call on the United Nations General Assembly to convene a High Level Meeting before September 2015 to assess progress toward the achievement of the goals in the 2011 Political Declaration and to renew the commitments to achieve Universal Access to HIV prevention, treatment, care and support in […]
“We are Canadian civil society organizations committed to the basic principle that access to medicines and to health care should be equitable, based on need and not on ability to pay, whether at home or around the world. Medicines should not be a luxury. We call on the Government of Canada to reject any proposals […]
Judging the epidemic has been prepared as a resource to help judges, magistrates, arbitrators and other judicial officers throughout the world adjudicate cases involving HIV-related issues. This handbook may also be used by judicial trainers and ministries of justice to deliver educational programmes to judges and magistrates on legal issues related to HIV and human […]